F376A/M388A‐solulin, a new promising antifibrinolytic for severe haemophilia A
Sign Up to like & getrecommendations! Published in 2017 at "Haemophilia"
DOI: 10.1111/hae.13126
Abstract: Haemophilia is a major bleeding disorder due to a deficiency of procoagulant factor VIII (type A) or IX (type B). The treatment is substitutive and based on infusion of factor concentrates. Main limitations of this… read more here.
Keywords: new promising; solulin new; factor; haemophilia f376a ... See more keywords